Scholarlink

<p>With the escalating global prevalence of obesity and metabolic syndrome, metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as the predominant chronic liver disease worldwide, which can ultimately result in liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Currently, with the effective control of viral hepatitis, MAFLD is emerging as an increasingly significant etiology for HCC. Despite the distinctive characteristics of MAFLD-related HCC (MAFLD-HCC) compared to other etiologies of HCC, its current etiology is not universally considered in all international clinical practice guidelines for HCC. In this review, we provide an overview of the prevalence, diagnostic criteria, challenges in early detection, and current treatment strategies for MAFLD-HCC. This comprehensive analysis aims to enhance understanding of MAFLD-HCC and optimize clinical management to improve patient prognosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diagnosis and treatment of metabolic dysfunction-associated fatty liver disease -related hepatocellular carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月13日

查看全文
  • Ke-Gong Xiong,
  • Tai-Shun Lin,
  • Qing-Biao Lin,
  • Jin-Feng Kong,
  • Kun-Yu Ke

摘要

With the escalating global prevalence of obesity and metabolic syndrome, metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as the predominant chronic liver disease worldwide, which can ultimately result in liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Currently, with the effective control of viral hepatitis, MAFLD is emerging as an increasingly significant etiology for HCC. Despite the distinctive characteristics of MAFLD-related HCC (MAFLD-HCC) compared to other etiologies of HCC, its current etiology is not universally considered in all international clinical practice guidelines for HCC. In this review, we provide an overview of the prevalence, diagnostic criteria, challenges in early detection, and current treatment strategies for MAFLD-HCC. This comprehensive analysis aims to enhance understanding of MAFLD-HCC and optimize clinical management to improve patient prognosis.